Home  /  Resource Library  /  Zanubrutinib is effective in non-germinal-center B-cell-like diffuse large B-cell lymphoma with mutated CD79B, high TCL1A expression, or over-expressed MYC/BCL-2

Zanubrutinib is effective in non-germinal-center B-cell-like diffuse large B-cell lymphoma with mutated CD79B, high TCL1A expression, or over-expressed MYC/BCL-2

Study investigated zanubrutinib for treatment against mutations in DLBCL.